Chart

11  Information according to article 663c of the Swiss Code of Obligations

 

11.1  Significant shareholders

The Company has knowledge of the following significant shareholders with shareholdings in excess of 3% of the issued share capital at December 31:1

 

31.12.2017

31.12.2018

Chase Nominees Ltd., London (UK)

13.3%

13.1%

NN Group N.V., Amsterdam (NL)

7.3%

7.2%

Massachusetts Mutual Life Insurance Company, Springfield MA (US)

4.9%

5.8%

UBS Fund Management (Switzerland) AG, Basel (CH)

4.9%

4.9%

BlackRock Inc., New York (US)

6.4%

4.9%

APG Algemene Pensioen Groep N.V., Amsterdam (NL)

4.9%

4.9%

T. Rowe Price Associates, Baltimore, MD (US)

<3.0%

3.0%

Norges Bank (the Central Bank of Norway), Oslo (NO)

3.0%

2.9%

Pictet Funds SA, Geneva (CH)

3.0%

2.9%

Wellington Management Group LLP, Boston (US)

3.0%

<3.0%

  1. Percentages are based on the most recent shareholder notifications to SIX, adjusted to the actual share capital at the end of the reporting period.
11.2  Share and option ownership of the Board of Directors and Management Board

For details of the employee participation plans please refer to note 11.4 of the consolidated financial statements.

 

11.2.1  Share and option ownership of the Board of Directors

 

Year

Total options

Total shares

Number

 

 

 

Dr. Lukas Braunschweiler

(Chairman, since April 2018)1

2017

2018

Rolf Classon 

(Chairman, until April 2018)2

2017

 7,293

2018

Heinrich Fischer 

(Vice Chairman)

2017

 16,237

2018

 16,550

Dr. Oliver S. Fetzer

2017

 2,248

2018

 2,498

Lars Holmqvist

2017

 625

2018

 875

Dr. Karen Hübscher

2017

 625

2018

 875

Dr. Christa Kreuzburg

2017

 1,474

2018

 1,724

Dr. Daniel R. Marshak
(since April 2018)1

2017

2018

Gérard Vaillant 

(until April 2018)2

2017

 2,248

2018

 

 

 

 

Balance at December 31, 2017

 

 30,750

Balance at December 31, 2018

 

22,522

  1. Shares and share options in 2017 are not disclosed, because the member of the Board joined after year-end 2017.
  2. Shares and share options in 2018 are not disclosed, because the member of the Board stepped down before year-end 2018.
11.2.2  Share and option ownership of the Management Board

 

Year

Total options

Total shares

Number

 

 

 

Dr. David Martyr (CEO)

2017

 21,930

2018

 20,268

Dr. Rudolf Eugster (CFO)

2017

 7,776

2018

 11,199

Ulrich Kanter

2017

 5,825

2018

 5,232

Dr. Achim von Leoprechting

2017

 5,943

2018

 5,393

Dr. Klaus Lun

2017

 5,512

2018

 5,053

Erik Norström

2017

 130

2018

 1,358

Markus Schmid

2017

 5,199

2018

4,495

Andreas Wilhelm

2017

 5,199

2018

4,495

 

 

 

 

Balance at December 31, 2017

 

 57,514

Balance at December 31, 2018

 

57,493